Clinical relevance of zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA

Overview of attention for article published in EMBO Molecular Medicine, December 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 10 news outlets
blogs: 4 blogs

twitter: 4 X users
bluesky: 2 Bluesky users

Readers on

mendeley: 15 Mendeley

So far, Altmetric has seen 4 Bluesky posts from 2 Bluesky users, with an upper bound of 4,863 followers.

😍 https://bsky.app/profile/did:plc:2gdibo6rzq76w63uvxtonntd/post/3mcuiiymdqk2x

Our new issue is online! link.springer.com/journal/44321 The cover illustrates the study by B. Stringer, J. Giacomotto & colleagues that introduces a tool for assessing SMN1 pathogenicity in #SpinalMuscularAtrophy using the zebrafish model ➡️ doi.org/10.…

RP @embomolmed.org: Clinical relevance of #zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA 👉 doi.org/10.1038/s443... #SpinalMuscularAtrophy By B. Stringer, J. Giacomotto and colleagues @griffith.edu.au

Clinical relevance of #zebrafish for gene variants testing. Proof-of-principle with SMN1/SMA 👉 doi.org/10.1038/s443... #SpinalMuscularAtrophy By B. Stringer, J. Giacomotto and colleagues @griffith.edu.au

This page shows the most recent Bluesky posts that mention this research output. Click here to find out how to access more activity.